The largest database of trusted experimental protocols

54 protocols using recombinant human gm csf

1

Isolation and Culture of Myeloid Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs were isolated from heparinized peripheral blood from healthy donors by density gradient centrifugation on Lymphoprep (Nycomed). For DC, macrophage, or LC culture, monocytes were isolated using Percoll (Pharmacia) density gradients. Cells were cultured for 6 days in IMDM (Lonza) containing 5% fetal bovine serum (FBS; Biowest) and 86 μg/mL gentamicin (Gibco) supplemented with 20 ng/mL recombinant human GM‐CSF (Invitrogen) and 2 ng/mL recombinant human IL‐4 (Miltenyi Biotec) for DCs, 20 ng/mL recombinant human GM‐CSF for macrophages, or 20 ng/mL recombinant human GM‐CSF, 2 ng/mL recombinant human IL‐4 and 10 μg/mL recombinant human TGF‐β1 (R&D Systems) for LCs. At day 2 or 3, half of the medium was replaced by fresh medium containing cytokines. Monocytes were isolated from PBMCs by MACS isolation using CD14 microbeads (Miltenyi Biotec) for direct stimulation or analysis.
+ Open protocol
+ Expand
2

Recombinant Proteins for Immune Cell Study

Check if the same lab product or an alternative is used in the 5 most similar protocols
HCVc (amino acids2–192) and β-galactosidase was obtained from meridian life science Inc (Saco, USA). Human recombinant GM-CSF, M-CSF, IFN-γ, Lipopolysaccharide (LPS), IL-4, IL-13, Pam3CSK4 and anti-TLR2 antibody were purchased from R&D (NewYork, USA).
+ Open protocol
+ Expand
3

Monocyte-derived Dendritic and Langerhans Cell Generation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral human blood of normal donors was obtained by buffy coats from the German Red Cross blood donation service, Berlin. All studies performed were in adherence to the Helsinki guidelines. By depletion of contaminating cells monocytes were magnetically isolated from PBMC (monocyte isolation kit II, Miltenyi Biotec, Bergisch Gladbach, Germany). In some studies, MoDCs and MoLCs were generated from the same donor blood. Cells were cultured in RPMI 1640 supplemented with 2 mM l-glutamine, 100 IU/mL penicillin, 100 µg/mL streptomycin and 10% (v/v) heat-inactivated FCS (Biochrom, Berlin, Germany) for 6 days with human recombinant GM-CSF (100 ng/mL), IL-4 (10 ng/mL), and TGF-β1 (for MoLCs only, 10 ng/mL, R&D Systems, Wiesbaden-Nordenstadt, Germany) [49 (link)].
+ Open protocol
+ Expand
4

Monocyte-Derived Dendritic Cell Generation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human monocytes were purified from peripheral blood lymphocytes were isolated by using Ficoll gradients (lympholyte-H; Cedarlane, Burlington, Ontario). CD14 cells were purified by positive sorting through anti-CD14 mAb-conjugated magnetic microbeads (Miltenyi Biotec, Bergisch Gladbach, Germany) and cultured in 75 cm2 flasks (Costar, Corning Life Sciences, Tewksbury, MA) in RPMI 1640 medium (Life Technologies Invitrogen), supplemented with heat-inactivated 10% lipopolysaccharide-free FBS, 1 mM sodium pyruvate, 0.1 mM nonessential amino acids, 2 mM L-glutamine, 25 mM HEPES, 100 U/ml penicillin, 100 µg/ml streptomycin (all from EuroClone, Milan, Italy) and 0.05 mM 2-βmercaptoethanol (Sigma Chemicals; St. Louis, MO) in the presence of human recombinant GM-CSF (25 ng/ml; R&D Systems, Minneapolis, MN) and IL-4 (25 ng/ml; R&D Systems) [21] (link). After 6 d, immature MDDC were washed and analyzed by cytofluorimetry for the expression of the surface markers CD1a, CD14, CD83 and CD38. MDDC were used in the experiments if >80% CD1a and <10% CD14 positive cells.
+ Open protocol
+ Expand
5

Netrin-1 and RvD1 Modulate Macrophage Phagocytosis

Check if the same lab product or an alternative is used in the 5 most similar protocols
For differentiation of Mϕ, peripheral blood monocytes were isolated from human leukapheresis collars from the Children’s Hospital Boston Blood Bank and cultured in RPMI with 10 ng/ml human recombinant GM-CSF (R&D Systems; 37°C for 7 d). To prepare apoptotic PMN, human PMNs obtained from peripheral blood were isolated and labeled with carboxyfluorescein diacetate (10 µM, 30 min at 37°C; Invitrogen) and allowed to undergo apoptosis in serum-free RPMI for 16–18 h. MΦ (0.106 cells/well) were incubated with human recombinant netrin-1 (R&D Systems) in the presence or absence of RvD1 (1 nM) Boc2 peptide (10−4 M; Santa Cruz Biotechnology, Inc.; 15 min at 37°C). Apoptotic PMNs were added at 1:3 ratio (MΦ/PMN) with phagocytosis incubations performed at 37°C for 60 min, and fluorescence was determined by using a fluorescent plate reader (SpectraMax; Molecular Devices).
+ Open protocol
+ Expand
6

Monocyte-Derived Dendritic Cell Generation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fifty to 70 ml of blood was taken by venous puncture. Peripheral blood mononuclear cells were isolated from heparinized blood by Ficoll-Paque (GE Healthcare) purification. Briefly, blood was diluted 1:1 with sodium chloride and tubes were centrifuged at 400g for 30 minutes with the brake off. Cells were harvested from the interface of the Ficoll layer, and were washed and enumerated. Monocytes were isolated using anti-CD14 microbeads, according to the manufacturer’s instruction (Miltenyi Biotec, San Diego, CA, USA). Cells were cultured in RPMI 1640 with 10% human serum and L-glutamine, pen/strep, non-essential amino acids, sodium pyruvate, 2-ME, 40 ng/ml of recombinant human IL-4 and 40 ng/ml of recombinant human GM-CSF (both from R&D Systems). Cytokines were replenished on days 3 and 6, and cells were used on day 7. For some experiments, CD4+ T cells were isolated from the CD14- fraction using the T cell isolation II kit (Miltenyi Biotec). Cells were then cultured with MoDCs in the presence or absence or RSV. At 48 hours, RNA was extracted and message levels of IFN-γ, IL-5 and IL-13 were determined by qPCR.
+ Open protocol
+ Expand
7

Engineered IDH2 Mutant Expression in TF-1 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
TF-1 cells (#CRL-2003, ATCC; purchased 2018; authentication and Mycoplasma not tested) were cultured in RPMI 1640 medium with 10% FBS and 2 ng/ml recombinant human GM-CSF (R&D Systems). MOLM14 (from D. Gary Gilliand’s lab; authentication and Mycoplasma not tested) cells were cultured in RPMI 1640 medium with 10% FBS. HEK293T (from D. Gary Gilliand’s lab; authentication and Mycoplasma not tested) was cultured in Dulbecco Modified Eagle Medium (DMEM) with 10% FBS. Cells were cultured at 37 with of 5% CO2. Stable overexpression of IDH2R140Q variants in TF-1 cells was conducted by using pLVX-IRES-Hyg vector harboring FLAG-tagged IDH2 R140Q, R140Q/K413R, or R140Q/K413Q. Briefly, to produce lentivirus, each construct was co-transfected into HEK293T cells using Lenti-X™ Packaging Single shots (Clontech) according to the manufacturer’s instructions. Lentivirus-containing supernatant medium was collected 48 hours after transfection, filtered before adding to the indicated host cell lines. 24 hours after infection, target cells were subjected to hygromycin selection (Invitrogen). The overexpression of proteins was confirmed by Western blotting using antibodies against IDH2.
+ Open protocol
+ Expand
8

Cell Culture Conditions for K562, HEL92.1.7, and TF-I

Check if the same lab product or an alternative is used in the 5 most similar protocols
K562, HEL92.1.7, and TF-I cell lines were purchased from American Type Culture Collection (ATCC). Cells were cultured in RPMI-1640 medium supplemented with 10% heat-inactivated fetal bovine serum (FBS, HyClone), 2 mM l-glutamine (Sigma-Aldrich) 100 U/ml penicillin and 100 μg/ml streptomycin (Sigma-Aldrich) at 37 °C in a humidified atmosphere of 5% CO2 in the air. Additionally, TF-I cells medium contained 2 ng/ml of recombinant human GM-CSF (R&D Systems). Cells have been cultured for no longer than 4 weeks after thawing and were regularly tested for Mycoplasma contamination using PCR technique and were confirmed to be negative.
+ Open protocol
+ Expand
9

Differentiation of Monocytes into Macrophages and Induced Microglia

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral blood was collected using a heparinized tube from healthy adult volunteers and a patient of NHD. Peripheral blood mononuclear cells (PBMC) were isolated by Histopaque-1077 (Sigma Chemical Co., St. Louis, MO) density gradient centrifugation. PBMC were resuspended with RPMI-1640 (Nacalai Tesque, Kyoto, Japan), 10% heat-inactivated fetal bovine serum (FBS; Endotoxin = 0.692 EU/ml; Japan Bio Serum, Hiroshima, Japan) and 1% antibiotics/antimycotic (Invitrogen, Carlsbad, CA). PBMC were plated onto culture chambers at a density of 4 × 105 cells/ml and cultured overnight in standard culture conditions (37°C, 5% CO2). After overnight incubation, culture supernatant and non-adherent cells were removed. The adherent cells (monocytes) were cultured with RPMI-1640 Glutamax (Invitrogen) supplemented with 1% antibiotics/antimycotic and a mixture of the following candidate cytokines; recombinant human GM-CSF (10 ng/ml; R&D Systems, Minneapolis, MN), recombinant human IL-34 (100 ng/ml; R&D Systems) and M-CSF (10 ng/ml; Peprotec, Rocky Hill, NJ) in order to develop iMG cells. We also developed induced macrophage from human monocytes; monocytes were cultured with RPMI-1640 Glutamax supplemented with 1% antibiotics/antimycotic and recombinant human GM-CSF (10 ng/ml). All cells were cultured in standard culture conditions for up to 14 days.
+ Open protocol
+ Expand
10

Culturing Monocyte-Derived Macrophages

Check if the same lab product or an alternative is used in the 5 most similar protocols
MEF (from CK Qu’s lab; authentication and Mycoplasma not test) were cultured in DMEM medium with 10% FBS and 2 ng/ml recombinant human GM-CSF (R&D Systems).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!